AtriCure (ATRC)
(Delayed Data from NSDQ)
$23.17 USD
+0.56 (2.48%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $23.16 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Income Statements
Fiscal Year end for AtriCure, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 399 | 330 | 274 | 207 | 231 |
Cost Of Goods | 99 | 84 | 68 | 57 | 60 |
Gross Profit | 300 | 246 | 206 | 149 | 170 |
Selling & Adminstrative & Depr. & Amort Expenses | 327 | 289 | 151 | 194 | 203 |
Income After Depreciation & Amortization | -27 | -43 | 55 | -44 | -33 |
Non-Operating Income | 4 | 1 | 0 | 1 | 2 |
Interest Expense | 7 | 5 | 5 | 5 | 4 |
Pretax Income | -30 | -46 | 50 | -48 | -35 |
Income Taxes | 1 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -30 | -46 | 50 | -48 | -35 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -30 | -46 | 50 | -48 | -35 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -11 | -29 | 151 | -33 | -24 |
Depreciation & Amortization (Cash Flow) | 16 | 14 | 96 | 11 | 9 |
Income After Depreciation & Amortization | -27 | -43 | 55 | -44 | -33 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 46.31 | 45.74 | 46.04 | 42.13 | 37.59 |
Diluted EPS Before Non-Recurring Items | -0.75 | -1.02 | -1.16 | -1.01 | -1.07 |
Diluted Net EPS (GAAP) | -0.66 | -1.02 | 1.09 | -1.14 | -0.94 |
Fiscal Year end for AtriCure, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 106.54 | 98.29 | 100.92 | 93.49 |
Cost Of Goods | NA | 26.73 | 24.42 | 23.84 | 23.89 |
Gross Profit | NA | 79.81 | 73.87 | 77.08 | 69.61 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 88.49 | 81.95 | 81.22 | 75.39 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -8.68 | -8.08 | -4.14 | -5.78 |
Non-Operating Income | NA | 1.05 | 0.85 | 0.84 | 1.02 |
Interest Expense | NA | 1.80 | 1.77 | 1.72 | 1.64 |
Pretax Income | NA | -9.42 | -9.01 | -5.03 | -6.40 |
Income Taxes | NA | 0.37 | 0.05 | 0.09 | 0.08 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -9.79 | -9.06 | -5.12 | -6.48 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -9.79 | -9.06 | -5.12 | -6.48 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 46.45 | 46.41 | 46.27 | 46.11 |
Diluted EPS Before Non-Recurring Items | NA | -0.21 | -0.20 | -0.12 | -0.23 |
Diluted Net EPS (GAAP) | NA | -0.21 | -0.20 | -0.11 | -0.14 |